Bridgefront Capital, LLC Charles River Laboratories International, Inc. Transaction History
Bridgefront Capital, LLC
- $249 Million
- Q3 2024
A detailed history of Bridgefront Capital, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bridgefront Capital, LLC holds 3,831 shares of CRL stock, worth $702,682. This represents 0.3% of its overall portfolio holdings.
Number of Shares
3,831
Previous 2,662
43.91%
Holding current value
$702,682
Previous $549,000
37.34%
% of portfolio
0.3%
Previous 0.23%
Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.12 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$933 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$686 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$391 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$356 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.33B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...